首页> 外国专利> LABEL-FREE SINGLE AND MULTI-PHOTON FLUORESCENCE SPECTROSCOPY TO DETECT BRAIN DISORDERS AND DISEASE: ALZHEIMER, PARKINSON AND AUTISM FROM BRAIN TISSUE, CELLS, SPINAL FLUID AND BODY FLUIDS

LABEL-FREE SINGLE AND MULTI-PHOTON FLUORESCENCE SPECTROSCOPY TO DETECT BRAIN DISORDERS AND DISEASE: ALZHEIMER, PARKINSON AND AUTISM FROM BRAIN TISSUE, CELLS, SPINAL FLUID AND BODY FLUIDS

机译:无标签单光子和多光子荧光光谱法检测脑部疾病和疾病:脑组织,细胞,脊髓液和体液中的阿尔齐默,帕金森症和自闭症

摘要

A label free single or multi-photon optical spectroscopy for measuring the differences between the levels of fluorophores from tryptophan, collagen, reduced nicotinamide adenine dinucleotide (NADH), and flavins exist in brain samples from a of Alzheimer's disease (AD) and in normal (N) brain samples with label-free fluorescence spectroscopy. Relative quantities of these molecules are shown by the spectral profiles of the AD and N brain samples at excitation wavelengths 266 nm, 300 nm, and 400 nm. The emission spectral profile levels of tryptophan and flavin were much higher in AD samples, while collagen emission levels were slightly lower and NADH levels were much lower in AD samples. These results yield a new optical method for detection of biochemical differences in animals and humans for Alzheimer's disease.
机译:用于检测色氨酸,胶原蛋白,还原烟酰胺腺嘌呤二核苷酸(NADH)和黄素的无标记单光子或多光子光谱技术之间的差异,这些蛋白来自阿尔茨海默氏病(AD)和正常人( N)无标记荧光光谱的脑样本。这些分子的相对量通过激发波长为266 nm,300 nm和400 nm的AD和N脑样本的光谱图显示。在AD样品中,色氨酸和黄素的发射光谱曲线水平高得多,而在AD样品中,胶原蛋白的发射水平略低,而NADH水平则低得多。这些结果产生了一种新的光学方法,用于检测动物和人类中阿尔茨海默氏病的生化差异。

著录项

  • 公开/公告号US2018078142A1

    专利类型

  • 公开/公告日2018-03-22

    原文格式PDF

  • 申请/专利权人 ROBERT ALFANO;LINGYAN SHI;

    申请/专利号US201715397431

  • 发明设计人 ROBERT ALFANO;LINGYAN SHI;

    申请日2017-01-03

  • 分类号A61B5;G01N33/483;G01N21/64;

  • 国家 US

  • 入库时间 2022-08-21 13:03:50

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号